The lawsuit alleges three manufacturers coordinated with three pharmacy benefit managers in a scheme to inflate insulin prices to make a higher profit.
PORTLAND, Ore. — Oregon Attorney General Dan Rayfield has filed a $900 million lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs). The lawsuit alleges the groups coordinated to artificially inflate the price of insulin and other diabetes medications in order to make a higher profit.
The lawsuit was filed on Wednesday in Multnomah County Circuit Court. It claims three insulin manufacturers — Novo Nordisk, Sanofi and Eli Lilly — boosted list prices in order to “secure favorable placement” on PBM formularies.
→ Continue reading at KGW TV